Ursodeoxycholic acid and bezafibrate were useful for steroid-refractory, immune-related hepatitis: a case report
ConclusionsUrsodeoxycholic acid and bezafibrate may be useful for treatment of steroid-refractory immune-related adverse event hepatitis.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: Cancer & Oncology | Chemotherapy | Corticosteroid Therapy | General Medicine | Hepatitis | Hepatitis A | Immunotherapy | Liver | Melanoma | Pneumonia | Prednisolone | Prograf | Skin Cancer | Tacrolimus | Urology & Nephrology